AbbVie (NY: ABBV )
185.93
+3.99
(+2.19%)
Streaming Delayed Price
Updated: 12:58 PM EDT, Jul 30, 2024
Add to My Watchlist
Headline News about AbbVie![]()
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
![]() ![]()
AbbVie's Migraine Treatment Scores Canadian Approval
November 16, 2022
Via Benzinga
![]()
Exicure Flags Bankruptcy Concerns, Shares Fall
November 15, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch
November 07, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Can Biotech Stocks Continue Rallying In This Bear Market?
October 31, 2022
Via Talk Markets
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|